Telix Innovations
SpainAll drugs from this manufacturer
-
It is used in adults with prostate cancer to perform an imaging test (PET) that helps detect if the cancer has spread to the lymph nodes or other tissues, if it has recurred after initial treatment, or to determine if a patient is suitable for a specific targeted therapy.
Dosage form: radiopharmaceutical preparation kit
Active substance Dosage gozetotide 25 µg